NCT06033521

A Study to Learn More About the Menopausal Hormone Therapies in Korea

Treatment Patterns of Menopausal Hormone Therapy in South Korea: a Nationwide Cohort Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,036,294 (actual)
• Sponsor: Pfizer · Industry
• Sex: Female
• Age: 40 Years – 59 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to learn about how the commonly used menopausal hormone therapies were prescribed and taken in practice. This is done by using healthcare database, to study the overall dangers and benefits of menopausal hormone therapies in real-world practice. This study will include subjects who were newly diagnosed menopausal symptoms between 2012 and 2019. They were all followed up for 12 months at least. The study included the below subjects who: * were aged 40-59 years * were diagnosed to have menopausal symptoms through some medical check-ups The data collected will be used to understand: * how the commonly used menopausal hormone therapies were prescribed and taken in practice * how patients took medication as prescribed by their doctors This might help to understand treatment trends of these therapies.

Conditions

• Menopause
• Bone Demineralization

Interventions

Type	Name	Description
DRUG	Menopausal hormone therapy Intervention Type: Drug	Subjects who were newly diagnosed menopausal symptoms between 01 Jan 2012 and 31 Dec 2019, and were followed up for 12 months at least in the HIRA claims database

Timeline

• Start date: 2023-09-12
• Primary completion: 2024-03-11
• Completion: 2024-03-11
• First posted: 2023-09-13
• Last updated: 2025-04-18
• Results posted: 2025-04-18

Locations

1 site across 1 country: South Korea

Regulatory

• FDA-regulated drug study